Drug Information

Drug General Information
Drug ID
D02WSB
Former ID
DNCL002675
Drug Name
CRS-207
Drug Type
Vaccine
Indication Mesothelioma; Metastatic pancreatic cancer [ICD9: 163, 185; ICD10:C45, C61] Phase 2 [524918]
Company
Aduro BioTech
Target and Pathway
Target(s) Mesothelin-ADC Target Info [533108]
NetPath Pathway TCR Signaling Pathway
References
Ref 524918ClinicalTrials.gov (NCT02243371) GVAX Pancreas Vaccine (With CY) and CRS-207 With or Without Nivolumab. U.S. National Institutes of Health.
Ref 533108Safety and survival with GVAX pancreas prime and Listeria Monocytogenes-expressing mesothelin (CRS-207) boost vaccines for metastatic pancreatic cancer. J Clin Oncol. 2015 Apr 20;33(12):1325-33.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.